Related Experiment Video
Updated: Oct 26, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Behavioral Strategies for Irritable Bowel Syndrome: Brain-Gut or Gut-Brain?
Christina H Jagielski1, Megan E Riehl2
1Internal Medicine-Gastroenterology, Michigan Medicine, 380 Parkland Plaza, Ann Arbor, MI 48103, USA.
Irritable Bowel Syndrome (IBS), a gut-brain interaction disorder, is worsened by stress and poor sleep. Behavioral therapies and mental health support improve quality of life and reduce IBS symptoms.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Psychiatry
Background:
- Irritable Bowel Syndrome (IBS) is a prevalent disorder of gut-brain interaction (DGBI).
- IBS significantly impacts physical, emotional, and occupational well-being.
- Factors like early life stress, sleep issues, and visceral hypersensitivity exacerbate IBS.
Purpose of the Study:
- To review the impact of psychological factors on IBS.
- To highlight the efficacy of behavioral interventions for IBS.
- To emphasize the role of mental health providers in comprehensive IBS care.
Main Methods:
- Literature review on gut-brain interaction in IBS.
- Analysis of behavioral therapies for gastrointestinal (GI) symptoms.
- Discussion of integrated care models for DGBIs.
Main Results:
- Psychological factors negatively influence gut-brain communication in IBS.
- Cognitive behavioral therapy, hypnosis, and mindfulness improve GI-specific quality of life.
- Behavioral strategies effectively reduce IBS symptom severity.
Conclusions:
- Addressing psychological factors is crucial for managing IBS.
- Behavioral interventions offer significant benefits for IBS patients.
- Collaboration between gastroenterologists and mental health professionals enhances IBS treatment outcomes.
More Related Videos
06:01Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Constipation-Predominant IBS